Azithromycin in the extremely low birth weight infant for the prevention of Bronchopulmonary Dysplasia: a pilot study

BACKGROUND: Azithromycin reduces the severity of illness in patients with inflammatory lung disease such as cystic fibrosis and diffuse panbronchiolitis. Bronchopulmonary dysplasia (BPD) is a pulmonary disorder which causes significant morbidity and mortality in premature infants. BPD is pathologica...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Ballard, Hubert O, Anstead, Michael I, Shook, Lori A
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2007
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1896160/
https://ncbi.nlm.nih.gov/pubmed/17550598
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1465-9921-8-41
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars